SOLICITATION NOTICE
66 -- ELISA Kits
- Notice Date
- 1/20/2010
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 325998
— All Other Miscellaneous Chemical Product and Preparation Manufacturing
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
- ZIP Code
- 20857-0001
- Solicitation Number
- 1068732
- Archive Date
- 2/19/2010
- Point of Contact
- Jaclyn Stielper, , Doreen Williams,
- E-Mail Address
-
jaclyn.stielper@fda.hhs.gov, doreen.williams@fda.hhs.gov
(jaclyn.stielper@fda.hhs.gov, doreen.williams@fda.hhs.gov)
- Small Business Set-Aside
- Total Small Business
- Description
- This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR 12.6, simplified acquisition procedures and the resultant purchase order will include all applicable provisions and clauses in effect through the Federal Acquisition Circular 05-35. This announcement constitutes the only 100% total small business set aside solicitation and a written solicitation will not be issued. This synopsis, NAICS code 325998, is to notify contractors that the government intends to issue a fixed price IDIQ (Indefinite Deliver Indefinite Quantity) Contract in accordance with FAR Part 13.106 for the following statement of work, under the simplified acquisition procedures. Any firm that believes it is capable of providing the required service as stated herein may submit a capability statement to document its ability to provide the required services. A determination to compete this procurement based on a response to this notice is solely within the discretion of the Government. The Government reserves the right to award a contract without discussions if the Contracting Officer determines that the initial offer(s) is/are providing the Best Value and discussions are not necessary. Award will be made to the party whose quote offers the best value to the Government. The Government may award this contract to other than the lowest price technically acceptable quote. Technical specifications and past performance are significantly more important than price. This solicitation is issued as a Request for Quotation (RFQ). The Food and Drug Administration (FDA) intends to award a purchase order for ELISA Kits Statement of Work (SOW) FDA has analytical data generated internally and provided by external sources indicating the presence of melamine in food components used to manufacture a variety of human and animal feed products including finished food products. In 2007, tainted pet food was linked to foreign sources of gluten and other bulk protein products originating from China. More recently, the illnesses of thousands of Chinese infants has been linked to the intentional addition of melamine to milk that was subsequently used as an ingredient in infant formula. This current situation has further raised the agency's concern regarding the practice of utilizing melamine to give the appearance that products contain a higher level of protein than they actually do for economic benefit. Several surveillance assignments have been issued recently to address the most current melamine situation. These assignments focus on the testing of milk derived components and finished food products containing milk derived components originating from foreign sources as well as the inspection of domestic infant formula manufacturers. During domestic infant formula inspections, samples of the milk derived components used to manufacture infant formula and finished products have been collected and tested for melamine. In addition to product containing dairy products, FDA has received reports of melamine found in products containing soy ingredients To support the efforts of the current import assignment, the FDA must screen large numbers of imported finished products. FDA scientists use the kits requested to rapidly screen defined food matrices for the presence of melamine. The specificity and sensitivity of the above-named kits have previously been evaluated by agency scientists and meet the stringent requirements established by the agency. Hence, the FDA has a critical need for such a large quantity of kits to detect the presence of the chemical adulterant melamine. CLIN0001: Melamine ELISA Kit, PN 50005B, Qnty: 50 CLIN0002: Shipping Charges Period of Performance The quantity mentioned above will be the minimum order and should be quoted against the base year below. Please provide a quote per kit for each option year below as well. Base Year: 02/15/2010 – 02/14/2011 Option Year 1: 02/15/2011 – 02/14/2012 Option Year 2: 02/15/2012 – 02/14/2013 Option Year 3: 02/15/2013 – 02/14/2014 Option Year 4: 02/15/2014 – 02/14/2015 Reporting Requirements and Deliverables. 8301 Muirkirk Road Laurel, MD 20708 Evaluation Criteria: 1.Contractor must demonstrate understanding of the requirement. 2.Contractor must demonstrate the same or similar past performance. 3.Cost CCR: Vendors must be registered in the Central Contractor Register (CCR) prior to the award of a contract. You may register by going to www.ccr.gov. You will need your Dun & Bradstreet number and banking information. QUESTIONS DEADLINE: All questions are to be submitted via email to Jaclyn.Stielper@fda.hhs.gov no later than January 30, 2010 at 3:00 PM EST. Telephone calls will not be accepted. QUOTATIONS DUE: All quotations are due, via email to: Jaclyn.Stielper@fda.hhs.gov, no later than 3:00 PM EST on February 4, 2010. PROVISIONS and CLAUSES: The provision at FAR 52.212-1, Instructions to Offerors Commercial Items applies to this solicitation. The following agenda has been attached to this provision: None. Offerors shall include a completed copy of the provision at FAR 52.212-3, Offeror Representations and Certifications Commercial Items. The clause at FAR 52.212-4, Contract Terms and Conditions, Commercial Items applies to this acquisition. The following agenda has been attached to the clause: None. The clause at FAR 52.212-5 Contract Terms and Conditions Required to Implement Statues or Executive Orders, Commercial Items applies to this acquisition. The following FAR clauses cited are applicable: FAR 52.217-8, FAR 52.217-9, FAR 52.222-26, FAR 52.222-35, FAR 52.222-36, and FAR 52.232-33. Clauses and provisions are incorporated by reference and apply to this acquisition.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/1068732/listing.html)
- Place of Performance
- Address: 8301 Muirkirk Road, Laurel, Maryland, 20708, United States
- Zip Code: 20708
- Zip Code: 20708
- Record
- SN02046039-W 20100122/100120235733-727aa47bec9611bee8b1df24a20836c6 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |